X-77683808-T-G
Variant names:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_000489.6(ATRX):c.1448A>C(p.Gln483Pro) variant causes a missense change. The variant allele was found at a frequency of 0.0000232 in 1,209,285 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 9 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.000036 ( 0 hom., 4 hem., cov: 23)
Exomes 𝑓: 0.000022 ( 0 hom. 5 hem. )
Consequence
ATRX
NM_000489.6 missense
NM_000489.6 missense
Scores
1
6
9
Clinical Significance
Conservation
PhyloP100: 4.24
Genes affected
ATRX (HGNC:886): (ATRX chromatin remodeler) The protein encoded by this gene contains an ATPase/helicase domain, and thus it belongs to the SWI/SNF family of chromatin remodeling proteins. This protein is found to undergo cell cycle-dependent phosphorylation, which regulates its nuclear matrix and chromatin association, and suggests its involvement in the gene regulation at interphase and chromosomal segregation in mitosis. Mutations in this gene are associated with X-linked syndromes exhibiting cognitive disabilities as well as alpha-thalassemia (ATRX) syndrome. These mutations have been shown to cause diverse changes in the pattern of DNA methylation, which may provide a link between chromatin remodeling, DNA methylation, and gene expression in developmental processes. Multiple alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.05219826).
BP6
Variant X-77683808-T-G is Benign according to our data. Variant chrX-77683808-T-G is described in ClinVar as [Benign]. Clinvar id is 465040.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.0000356 (4/112301) while in subpopulation EAS AF= 0.00111 (4/3611). AF 95% confidence interval is 0.000378. There are 0 homozygotes in gnomad4. There are 4 alleles in male gnomad4 subpopulation. Median coverage is 23. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 4 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATRX | NM_000489.6 | c.1448A>C | p.Gln483Pro | missense_variant | Exon 9 of 35 | ENST00000373344.11 | NP_000480.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000356 AC: 4AN: 112301Hom.: 0 Cov.: 23 AF XY: 0.000116 AC XY: 4AN XY: 34467
GnomAD3 genomes
AF:
AC:
4
AN:
112301
Hom.:
Cov.:
23
AF XY:
AC XY:
4
AN XY:
34467
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000821 AC: 15AN: 182813Hom.: 0 AF XY: 0.0000148 AC XY: 1AN XY: 67521
GnomAD3 exomes
AF:
AC:
15
AN:
182813
Hom.:
AF XY:
AC XY:
1
AN XY:
67521
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000219 AC: 24AN: 1096984Hom.: 0 Cov.: 32 AF XY: 0.0000138 AC XY: 5AN XY: 362410
GnomAD4 exome
AF:
AC:
24
AN:
1096984
Hom.:
Cov.:
32
AF XY:
AC XY:
5
AN XY:
362410
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000356 AC: 4AN: 112301Hom.: 0 Cov.: 23 AF XY: 0.000116 AC XY: 4AN XY: 34467
GnomAD4 genome
AF:
AC:
4
AN:
112301
Hom.:
Cov.:
23
AF XY:
AC XY:
4
AN XY:
34467
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
10
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Alpha thalassemia-X-linked intellectual disability syndrome Benign:1
Mar 20, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Benign
DEOGEN2
Benign
.;.;T;T;.
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;.;D;D;D
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T;T;T
MetaSVM
Uncertain
D
PrimateAI
Benign
T
PROVEAN
Benign
N;N;.;.;.
REVEL
Uncertain
Sift
Uncertain
D;D;.;.;.
Sift4G
Benign
T;T;T;.;T
Polyphen
B;.;.;.;.
Vest4
MutPred
Gain of glycosylation at Q483 (P = 0.0762);.;.;Gain of glycosylation at Q483 (P = 0.0762);.;
MVP
MPC
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at